# Karl Kieburtz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/karl-kieburtz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,299 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 69 |
| i10-index | 157 |
| Last Known Institution | Beth Israel Deaconess Medical Center |
| OpenAlex ID | https://openalex.org/A5030324367 |
| ORCID iD | https://orcid.org/0000-0002-1645-6921 |
| Works | 247 |

## Researcher papers

- [Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030](https://scholariq.org/papers/projected-number-of-people-with-parkinson-disease-in-the-most-populous-nations/)
- [Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease](https://scholariq.org/papers/phase-3-trials-of-solanezumab-for-mild-to-moderate-alzheimer-s-disease/)
- [Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study](https://scholariq.org/papers/continuous-intrajejunal-infusion-of-levodopa-carbidopa-intestinal-gel-for/)
- [The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort](https://scholariq.org/papers/the-parkinson-s-progression-markers-initiative-ppmi-establishing-a-pd-biomarker/)
- [HIV-associated cognitive impairment before and after the advent of combination therapy](https://scholariq.org/papers/hiv-associated-cognitive-impairment-before-and-after-the-advent-of-combination/)
- [Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort](https://scholariq.org/papers/longitudinal-change-of-clinical-and-biological-measures-in-early-parkinson-s/)
- [Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression](https://scholariq.org/papers/validation-of-serum-neurofilament-light-chain-as-a-biomarker-of-parkinson-s/)
- [Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls](https://scholariq.org/papers/longitudinal-csf-biomarkers-in-patients-with-early-parkinson-disease-and-healthy/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [Nuclear Receptors and Signaling](https://scholariq.org/topics/nuclear-receptors-and-signaling/)

## Researcher university

- [Beth Israel Deaconess Medical Center](https://scholariq.org/institutions/beth-israel-deaconess-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.